NEWS10 February 2010
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
NEWS10 February 2010
US— IMS Health has reported a 3% rise in revenue for the final quarter of 2009, in what is likely to be its last results announcement before becoming a privately-held company.
The healthcare data giant said sales increased to $599.2m for the three months ended 31 December. Operating income was down by 16% to $106.3m while net profit fell 27% to $71.5m
IMS said income was negatively affected by restructuring charges, costs associated with its planned takeover by investment groups TPG Capital and the CCP Investment Board, and other expense items totalling $27.7m. Adjusted figures show net profit up almost 5% to $95.1m.
Last summer, the firm announced a year-long plan to cut 850 jobs globally alongside other cost-reduction measures off the back of revenue falls in Q1 and Q2. Third-quarter sales also declined, but less severly than in previous quarters.
IMS chief executive David Carlucci (pictured) said: “IMS finished the year with an improved fourth-quarter performance, reflecting solid sequential revenue growth and better demand in the second half of the year. Our cost reduction plans remain on track.”
Full-year revenue was down 6% to $2.19bn, while net income fell 17% to $258.5m.
IMS shareholders voted earlier this week in favour of TPG and CCP’s $5bn takeover of the company. Save for a few remaining conditions, the deal is expected to complete before the end of the first quarter.
0 Comments